About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
Seminars in Hematology
›
Top Articles
Seminars in Hematology
Hematology
4
(top 4%)
Impact Factor
4.3
(top 4%)
extended IF
112
(top 3%)
H-Index
473
authors
2.7K
papers
81.8K
citations
4.1K
citing journals
21.7K
citing authors
Most Cited Articles of Seminars in Hematology
Title
Year
Citations
Primary systemic amyloidosis: clinical and laboratory features in 474 cases
1995
763
Rituximab: mechanism of action
2010
519
Chronic graft-versus-host disease and other late complications of bone marrow transplantation
1991
515
Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. The Fatigue Coalition
1997
449
Epidemiology and risk factors for venous thrombosis
2007
437
The Functional Assessment of Cancer Therapy-Anemia (FACT-An) Scale: a new tool for the assessment of outcomes in cancer anemia and fatigue
1997
436
Antimicrobial mechanisms in neutrophilic polymorphonuclear leukocytes
1975
365
Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols
1986
350
Therapeutic goals in the treatment of Gaucher disease
2004
347
Diagnosis and classification of the polycythemias
1975
332
Pathophysiology of graft-versus-host disease
2006
322
A dirty dozen: twelve p-value misconceptions
2008
319
Function and regulation of transferrin and ferritin
1998
307
Essential thrombocythemia: an interim report from the Polycythemia Vera Study Group
1986
301
Multiple myeloma: clinical evaluation of plasma cell lymphoproliferative disorders and initial management
1997
277
Bcl-2 family proteins: regulators of apoptosis and chemoresistance in hematologic malignancies
1997
248
Red blood cell deformability, membrane material properties and shape: regulation by transmembrane, skeletal and cytosolic proteins and lipids
1993
245
Familial constitutional panmyelocytopathy, Fanconi's anemia (F.A.). I. Clinical aspects
1967
236
Mantle-cell lymphoma
1999
236
Fundamentals of the psoralen-based Helinx[trade ] technology for inactivation of infectious pathogens and leukocytes in platelets and plasma
2001
234
The anemia of chronic disorders
1966
228
Blood group ABH and Ii antigens of human erythrocytes: chemistry, polymorphism, and their developmental change
1981
226
Iron sequestration and anemia of inflammation
2009
220
Epidemiology of anemia in older adults
2008
218
Effective risk stratification of surgical and nonsurgical patients for venous thromboembolic disease
2001
196
previous
2007
2008
2009
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.